{"status":"success","data":{"title":"Upper GI Bleed","slug":"upper-GI-bleed","tags":["aspirin","warfarin","Octreotide"],"collection":["gastroenterology","ebm"],"content":"\n# Upper GI Bleed\n\n**Common causes**\n\n-   Peptic ulcer disease (PUD): most common (55%)\n-   Esophageal varices\n-   Gastritis\n-   Mallory-Weiss tears\n\n**Risk Factors**\n\n-   Medications\n  - <span class=\"drug\">aspirin</span>, <span class=\"drug\">warfarin</span>, anticoagulant, NSAIDs, glucocorticoids\n-   Coagulopathies\n-   HIV infection\n-   Liver disease\n-   Prior GI bleed\n-   Prior irradiation for prostate/pelvic cancer\n-   Tobacco use\n-   Alcohol use\n-   Vascular disease\n\n**Mortality from upper GI bleed (UGIB):**\n\n-   Peptic ulcer disease (PUD) = 4%\n-   Esophageal varices = 50%\n\n\n## Physical Exam\n\n-   Iron or bismuth ingestion can result in melanotic stool → fecal occult blood negative\n-   Beets ingestion can result in red stool → fecal occult blood negative\n-   Melena occurs with as little as 50 mL of blood in stomach\n\n## Diagnostic Testing\n\n-   BUN/Cr\n-   Hematocrit and platelet count\n-   Liver function test\n-   PT/PTT\n-   Type and screen (or cross)\n-   EKG, if significant bleed and/or risk for ACS\n\n## Transfusions\n\n-   **pRBC:** Target hematocrit for:\n    -   Variceal bleed: Goal = 27 (conservative transfusion because of rebleed risk)\n    -   Young patient without CV risk: Goal = 25-27\n-   **FFP:** Should also be given for patients with coagulopathy and for every 4 pRBC units (add 1 unit FFP per 4 units pRBC)\n    -   Dose: 10-15 cc/kg with 1 unit of FFP containing 200 cc (per Rosen text)\n    -   Typical adult dose = 3-4 units FFP\n-   **Platelets:** Indicated for platelets &lt; 50K in setting of active bleed\n    -   Dose: 1 pack platelets/10 kg. Typical adult dose = 6 units (\"6 pack\") = 1 apheresis unit. 1 pack raises platelet count 5K-10K (per Roberts/Hedges text)\n\n## Medications\n\n**H2 blockers**: No benefit.\n**Proton pump inhibitor (PPI)**: Reduces risk of rebleeding, need for surgical intervention and transfusion. Questionable if mortality reduction.\n**<span class=\"drug\">Octreotide</span>**: Decreases risk for persistent and recurrent bleeding from variceal and nonvariceal bleeding. Decreases need for transfusion. No mortality reduction.\n-    Dose: 50 mcg IV bolus and then 50 mcg/hr IV drip\n\n## Likelihood Ratios of UGIB\n\n### Signs\n\n| Finding | +LR | -LR |\n|---------|-----|-----|\n| Melena on exam              | 25 (4-174)  | 0.52 (0.42-0.64)  |\n| NG Lavage with blood or coffee grounds |  9.6 (4-23)  | 0.58 (.049-0.70)  |\n| Clots in stool  | 0.05 (0.01-0.38)  | 1.2 (1.1-1.2) |\n\n### Labs\n\n| Finding | +LR | -LR |\n|---------|-----|-----|\n| BUN/Cr ratio > 30 | 7.5 (2.8-12)  | 0.53 (0.28-0.78) |\n\n## Likelihood of Severe Bleeding Requiring intervention\n\n### History\n\n| Finding | +LR | -LR |\n|---------|-----|-----|\n| Cirrhosis or malignancy hx  | 3.7 (1.6-8.8) | 0.83 (0.72-0.97) |\n| Syncope   | 3.0 (1.7-5.4) | 0.95 (0.91-0.98)  |\n| Using analgesics  | 2.6 (1.3-5.2) | 0.92 (0.84-0.99)  |\n| Coffee ground emesis  | 0.41 (0.26-0.64)  | 1.1 (1.1-1.2) |\n\n### Signs\n\n| Finding | +LR | -LR |\n|---------|-----|-----|\n| Pulse > 100/min | 4.9 (3.2-7.6) | 0.34 (0.22-0.53)  |\n| NG lavage with red blood  | 3.1 (1.2-14)  | 0.32 (0.17-0.57)  |\n| NG lavage with red blood or coffee grounds  | 2.0 (1.0-4.0) | 0.40 (0.20-0.81)  |\n| Hypotension | 1.2-4.8 | 0.51-0.78 |\n\n### Labs\n\n| Finding | +LR | -LR |\n|---------|-----|-----|\n| Hgb < 8 g/dL  | 4.5-6.2   | 0.36-0.41 |\n| BUN > 90 mg/dL  | 3.6 (2.4-5.5) | 0.45 (0.31-0.65) |\n| WBC > 12  | 3.4 (2.2-5.1) | 0.48 (0.34-0.68)  |\n\n\n## Blatchford Score\n\nValidated decision tool to identify UGIB patients who DON'T need urgent intervention\n\n**Serum BUN (mg/dL)**\n\n| Finding     | Score |\n|-------------|:-----:|\n| < 18.2      | 0     |\n| 18 - 22.4   | 2     |\n| 22.4 - 28.0 | 3     |\n| 28 - 70.0   | 4     |\n| &ge; 70.0   | 6     |\n\n**Hemoglobin (men, g/dL)**\n\n| Finding     | Score |\n|-------------|:-----:|\n| > 13        | 0     |\n| 12 - 12.9   | 1     |\n| 10 - 11.9   | 3     |\n| < 10        | 6     |\n\n**Hemoglobin (women, d/gL)**\n\n| Finding     | Score |\n|-------------|:-----:|\n| > 12        | 0     |\n| 10 - 11.9   | 1     |\n| < 10        | 6     |\n\n**SBP (mmHg)**\n\n| Finding     | Score |\n|-------------|:-----:|\n| > 109       | 0     |\n| 100-109     | 1     |\n| 90-99       | 2     |\n| < 90        | 3     |\n\n**Others**\n\n| Finding     | Score |\n|-------------|:-----:|\n| Pulse > 100/min | 1 |\n| Melena on Exam  | 1 |\n| Syncope         | 2 |\n| Hepatic disease | 2 |\n| Heart failure   | 2 |\n\n### Likelihood Ratio of Need for Urgent Evaluation by Score\n\n| Blatchford Score | +LR | -LR |\n|---------|-----|-----|\n| 0       | 1.2 (1.0-1.3) | 0.2 (0-0.05)  |\n| &le; 2  | 1.4 (1.1-1.8) | 0.08 (0.01-0.41)  |\n\n## References\n\n-   [Kumar R, Mills AM. GI Bleeding. EM Clin N Am. 2011; 29:239-52.](http://www.ncbi.nlm.nih.gov/pubmed/?term=21515178)\n-   [Srygley FD et al. Does this patient have a severe UGIB? JAMA. Mar 14, 2012; 307(10):1072-9.](http://www.ncbi.nlm.nih.gov/pubmed/?term=22416103)\n"}}